Literature DB >> 8452153

Multisystem damage associated with tricorporal priapism in sickle cell disease.

J R Sharpsteen1, D Powars, C Johnson, Z R Rogers, W D Williams, R J Posch.   

Abstract

PURPOSE: Priapism is an uncommon but debilitating complication of sickle cell disease (SCD). Recent observations among adult males regarding the abysmal failure of medical and surgical therapy encouraged us to review our 25-year experience identifying the prognostic features that might determine outcome. PATIENTS AND METHODS: As part of a prospective 25-year longitudinal demographic and clinical cohort study, a subset of 38 (8.2%) patients with priapism were identified among a cohort of 461 men with SCD. The patients with priapism were compared with the nonaffected men with respect to severity of disease expression, hematologic status, beta s globin gene haplotype, and the incidence of sickle-related major organ failure. The influence of the treatment modalities on outcome was also evaluated.
RESULTS: Priapism occurred as a single episode in 24 patients, and in 14 as temporally clustered repeat episodes. Eighty-seven percent of those with priapism had sickle cell anemia (SS), an increased risk as compared with other variants of SCD (p = < 0.05). There were two distinct age-related patterns of disease expression. Eight patients were prepubertal; they experienced shorter episodes, involvement of the corpora cavernosa only, few recurrent episodes, and a good prognosis for future erectile function. Non-surgical therapy in children was associated with excellent results. In contrast, the 29 postpubertal adults often had involvement of the corpora cavernosa and corpus spongiosa (tricorporal disease) and half had prolonged episodes that lasted longer than 8 days. One pubescent patient had repeated episodes and became impotent. Prolonged or repeated episodes eventuated in impotence in 56%. Surgical intervention was not beneficial. Sickle cell-related organ failure such as stroke, chronic restrictive lung disease, chronic renal failure, and nonhealing leg ulcers was observed more frequently in men who had priapism. Death occurred in nine adult patients (25%) within 5 years of the first episode of priapism.
CONCLUSION: Priapism in adult males identifies those at high risk for other sickle cell-related organ failure syndromes and, as such, is another complication indicative of severe disease. The dismal prognosis in SS adults requires better understanding of the precise pathophysiology of low-flow tricorporal priapism. Clarification of the mechanisms inducing the priapic state should lead to specific therapeutic maneuvers and an improved prognosis for this disabling condition.

Entities:  

Mesh:

Year:  1993        PMID: 8452153     DOI: 10.1016/0002-9343(93)90061-s

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

Review 1.  Priapism in sickle-cell disease: a hematologist's perspective.

Authors:  Gregory J Kato
Journal:  J Sex Med       Date:  2011-05-06       Impact factor: 3.802

Review 2.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

3.  Paediatric priapism--treatment conundrum.

Authors:  Amar Shah; Karan Parashar; Harish Chandran
Journal:  Pediatr Surg Int       Date:  2004-10       Impact factor: 1.827

Review 4.  What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

Authors:  S Minhas; A Salonia; M Gül; B Luca; K Dimitropoulos; P Capogrosso; U Milenkovic; A Cocci; R Veeratterapillay; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; A Kalkanli; M I Omar; C Bettocchi; J Carvalho; G Corona; T H Jones; A Kadioglu; J I Martinez-Salamanca; E C Serefoglu; P Verze
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

Review 5.  Priapism: pathophysiology and the role of the radiologist.

Authors:  J E Halls; D V Patel; M Walkden; U Patel
Journal:  Br J Radiol       Date:  2012-09-06       Impact factor: 3.039

Review 6.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

7.  Trends in Sickle Cell Disease-related Priapism in U.S. Children's Hospitals.

Authors:  Hsin-Hsiao Scott Wang; Katherine W Herbst; Jennifer A Rothman; Nirmish R Shah; John S Wiener; Jonathan C Routh
Journal:  Urology       Date:  2015-12-07       Impact factor: 2.649

8.  Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.

Authors:  Mina Cintho Ozahata; Grier P Page; Yuelong Guo; João Eduardo Ferreira; Carla Luana Dinardo; Anna Bárbara F Carneiro-Proietti; Paula Loureiro; Rosimere Afonso Mota; Daniela O W Rodrigues; André Rolim Belisario; Claudia Maximo; Miriam V Flor-Park; Brian Custer; Shannon Kelly; Ester Cerdeira Sabino
Journal:  J Sex Med       Date:  2019-10-24       Impact factor: 3.802

9.  Prevalence of Priapism and Its Awareness amongst Male Homozygous Sickle Cell Patients in Lagos, Nigeria.

Authors:  Adewumi Adediran; Kikelomo Wright; Akinsegun Akinbami; Adedoyin Dosunmu; Olajumoke Oshinaike; Bodunrin Osikomaiya; Sarah Ajibola; Kamal Ismail; Ebele Uche; Olaitan Ojelabi
Journal:  Adv Urol       Date:  2013-07-15

10.  Recurrent posterior reversible encephalopathy syndrome in a patient with sickle cell disease.

Authors:  Bimal Kumar Parameswaran; Pudukode Ramnath Krishnan; Jamila Al Dossary
Journal:  Ann Saudi Med       Date:  2007 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.